Survival and prognostic factors in patients treated with stereotactic radiotherapy for brain metastases

References

• Jenkinson MD, Haylock B, Shenoy A, Husband D, Javadpour M. Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. Eur J Cancer 2011;47:649–55.
   PubMed Web of Science ®Google Scholar
• Chang EL, Wefel JS, Maor MH, Hassenbusch SJ, 3rd, Mahajan A, Lang FF, et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 2007;60:277–83; discussion 283–4.
   PubMed Web of Science ®Google Scholar
• Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial. J Clin Oncol 2004;22:157–65.
   PubMed Web of Science ®Google Scholar
• Weissman DE. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: A review. J Clin Oncol 1988;6:543–51.
   PubMed Web of Science ®Google Scholar
• Khuntia D, Brown P, Li J, Mehta MP. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 2006;24:1295–304.
   PubMed Web of Science ®Google Scholar
• Sahgal A, Soliman H, Larson DA. Whole-brain radiation therapy of brain metastasis. Prog Neurol Surg 2012;25: 82–95.
   PubMedGoogle Scholar
• Sundstrom JT, Minn H, Lertola KK, Nordman E. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med 1998;30:296–9.
   PubMed Web of Science ®Google Scholar
• Tsao MN, Rades D, Wirth A, Lo SS, Danielson BL, Gaspar LE, et al. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2012;2:210–25.
   PubMedGoogle Scholar
• Hasegawa T, Kondziolka D, Flickinger JC, Germanwala A, Lunsford LD. Brain metastases treated with radiosurgery alone: An alternative to whole brain radiotherapy?Neurosurgery 2003;52:1318–26; discussion 1326.
   PubMed Web of Science ®Google Scholar
• Alexander III E, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995;87:34–40.
   PubMed Web of Science ®Google Scholar
• Karlsson B, Hanssens P, Wolff R, Soderman M, Lindquist C, Beute G. Thirty years’ experience with Gamma Knife surgery for metastases to the brain. J Neurosurg 2009; 111:449–57.
   PubMed Web of Science ®Google Scholar
• Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952–26001 study. J Clin Oncol 2011;29:134–41.
   PubMed Web of Science ®Google Scholar
• Buatti JM, Friedman WA, Bova FJ, Mendenhall WM. Treatment selection factors for stereotactic radiosurgery of intracranial metastases. Int J Radiat Oncol Biol Phys 1995;32:1161–6.
   PubMed Web of Science ®Google Scholar
• Becker G, Jeremic B, Engel C, Buchgeister M, Paulsen F, Duffner F, et al. Radiosurgery for brain metastases: The Tuebingen experience. Radiother Oncol 2002;62:233–7.
   PubMed Web of Science ®Google Scholar
• Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, et al. Stereotactic radiosurgery for brain metastases: Analysis of outcome and risk of brain radionecrosis. Radiat Oncol 2011;6:48.
   PubMed Web of Science ®Google Scholar
• DiLuna ML, King JT, Jr, Knisely JP, Chiang VL. Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases. Cancer 2007;109:135–45.
   PubMed Web of Science ®Google Scholar
• Cho KH, Hall WA, Gerbi BJ, Higgins PD, Bohen M, Clark HB. Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery. J Neurooncol 1998;40:73–86.
   PubMed Web of Science ®Google Scholar
• Likhacheva A, Pinnix CC, Parikh NR, Allen PK, McAleer MF, Chiu MS, et al. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2013;85:656–61.
   PubMed Web of Science ®Google Scholar
• Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994;28:797–802.
   PubMed Web of Science ®Google Scholar
• Gerdan L, Segedin B, Nagy V, Khoa MT, Trang NT, Schild SE, et al. Brain metastasis from non-small cell lung cancer (NSCLC): Prognostic importance of the number of involved extracranial organs. Strahlenther Onkol 2014;190:64–7.
   PubMed Web of Science ®Google Scholar
• Gerdan L, Segedin B, Veninga T, Schild SE, Rades D. Number of involved extracranial organs predicts survival in patients with brain metastasis from small cell lung cancer. Anticancer Res 2013;33:3887–9.
   PubMed Web of Science ®Google Scholar
• Rades D, Gerdan L, Segedin B, Nagy V, Khoa MT, Trang NT, et al. Brain metastasis. Prognostic value of the number of involved extracranial organs. Strahlenther Onkol 2013; 189:996–1000.
   PubMed Web of Science ®Google Scholar
• Manning MA, Cardinale RM, Benedict SH, Kavanagh BD, Zwicker RD, Amir C, et al. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys 2000;47:603–8.
   PubMed Web of Science ®Google Scholar
• Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial. Lancet Oncol 2009;10:1037–44.
   PubMed Web of Science ®Google Scholar
• Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial. JAMA 2006;295:2483–91.
   PubMed Web of Science ®Google Scholar